Naltrexone/Bupropion

被引：0
|
作者：
不详
机构：
来源：
DRUGS IN R&D | 2010年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In March 2010, Orexigen (R) Therapeutics submitted a new drug application (NDA) for approval of naltrexone sustained release (SR)/bupropion SR (Contrave (R)) for the treatment of obesity in the US. The tablet contains naltrexone SR 32mg and bupropion SR 360 mg. The drug has been tested in four randomized, double-blind, placebo-controlled, phase III trials and the coprimary endpoints were met in each case. This review discusses the key development milestones and clinical trial program to date.
引用
收藏
页码：25 / 32
页数：8
相关论文
共 50 条
  • [1] Naltrexone/bupropion: Contrave®; Naltrexone SR/bupropion SR
    不详
    Drugs in R & D, 2010, 10 (1) : 25 - 32
  • [2] Bupropion and naltrexone for the treatment of obesity
    Greenway, Frank L.
    Anderson, James W.
    Atkinson, Richard L.
    Fujioka, Ken
    Gadde, Kishore M.
    Gupta, Alok K.
    O'Neil, Patrick M.
    Schumacher, Donald
    Smith, Diane K.
    Whitehouse, M. J.
    Cruickshank, Scott
    Guttadauria, Maria
    Cowley, Michael A.
    DIABETES, 2006, 55 : A394 - A394
  • [3] Cardiovascular safety of naltrexone and bupropion
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (05): : 390 - 390
  • [4] Naltrexone and bupropion for weight loss
    Thomas, Betsy
    Lindblad, Adrienne J.
    Luu, Thao
    Paige, Allison
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : E179 - E180
  • [5] Naltrexone/bupropion prolonged release
    Llano, Andrea
    PRACTICAL DIABETES, 2015, 32 (03) : 114 - 115
  • [6] Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
    Dahlberg, Sarah
    Chang, Ellen
    Weiss, Sheila R.
    Dopart, Pamela
    Gould, Errol
    Ritchey, Mary E.
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3049 - 3067
  • [7] Naltrexone-bupropion for weight loss
    Thomas, Betsy
    Lindblad, Adrienne J.
    Luu, Thao
    Paige, Allison
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : 627 - 627
  • [8] Naltrexone/Bupropion (Contrave) for Weight Loss
    Early, Jessica
    Whitten, Jean Suzin
    AMERICAN FAMILY PHYSICIAN, 2015, 91 (08) : 554 - +
  • [9] Bupropion and Naltrexone in Methamphetamine Use Disorder
    Trivedi, Madhukar H.
    Walker, Robrina
    Ling, Walter
    dela Cruz, Adriane
    Sharma, Gaurav
    Carmody, Thomas
    Ghitza, Udi E.
    Wahle, Aimee
    Kim, Mora
    Shores-Wilson, Kathy
    Sparenborg, Steven
    Coffin, Phillip
    Schmitz, Joy
    Wiest, Katharina
    Bart, Gavin
    Sonne, Susan C.
    Wakhlu, Sidarth
    Rush, A. John
    Nunes, Edward V.
    Shoptaw, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 140 - 153
  • [10] Bupropion and naltrexone association on obesity treatment
    Ogura, Bianca Ayumi
    Mascarenhas, Nayandra Malta
    da Silva, Lia Aguiar
    Rampazzo, Maria Clara Semprebom
    Perek, Ellen Cristina
    de Almeida, Georgia Fernandes
    Gasques, Luciano Seraphim
    RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO, 2024, 18 (117): : 1295 - 1306
12345